Companies covered: Fibrocell Science Inc (NASDAQ:FCSC), Affymetrix, Inc. (NASDAQ:AFFX), Bruker Corporation (NASDAQ:BRKR), Fluidigm Corporation (NASDAQ:FLDM), Illumina, Inc. (NASDAQ:ILMN), Pacific Biosciences of California, Inc. (NASDAQ:PACB), PerkinElmer, Inc. (NYSE:PKI), Waters Corporation (NYSE:WAT), Veracyte, Inc. (NASDAQ:VCYT), Rosetta Genomics Ltd. (NASDAQ:ROSG), TrovaGene, Inc. (NASDAQ:TROV), T2 Biosystems, Inc. (NASDAQ:TTOO), Thermo Fisher Scientific Inc (NYSE:TMO), Roche Holdings Ltd. (ADR) (OTCMKTS:RHHBY), Agilent Technologies, Inc. (NYSE:A), Becton, Dickinson and Company (NYSE:BDX), Bio-Rad Laboratories, Inc. (NYSE:BIO), Danaher Corporation (NYSE:DHR), Pall Corporation (NYSE:PLL), Bio-Techne Corp (NASDAQ:TECH), Medgenics, Inc. (NYSEMKT:MDGN), Spectral Medical Inc. (TSE:EDT), Amarantus BioScience Holdings, Inc. (OTCMKTS:AMBS), Cesca Therapeutics Inc. (NASDAQ:KOOL)
